BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Belarmino G, Gonzalez MC, Sala P, Torrinhas RS, Andraus W, D’albuquerque LAC, Pereira RMR, Caparbo VF, Ferrioli E, Pfrimer K, Damiani L, Heymsfield SB, Waitzberg DL. Diagnosing Sarcopenia in Male Patients With Cirrhosis by Dual-Energy X-Ray Absorptiometry Estimates of Appendicular Skeletal Muscle Mass. JPEN J Parenter Enteral Nutr 2017. [DOI: 10.1177/0148607117701400] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Haj Ali S, Abu Sneineh A, Hasweh R. Nutritional assessment in patients with liver cirrhosis. World J Hepatol 2022; 14(9): 1694-1703 [DOI: 10.4254/wjh.v14.i9.1694] [Reference Citation Analysis]
2 Hey P, Hoermann R, Gow P, Hanrahan TP, Testro AG, Apostolov R, Sinclair M. Reduced upper limb lean mass on dual energy X-ray absorptiometry predicts adverse outcomes in male liver transplant recipients. World J Transplant 2022; 12(6): 120-130 [DOI: 10.5500/wjt.v12.i6.120] [Reference Citation Analysis]
3 Son SW, Song DS, Chang UI, Yang JM. Definition of Sarcopenia in Chronic Liver Disease. Life (Basel) 2021;11:349. [PMID: 33923561 DOI: 10.3390/life11040349] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Eriksen CS, Kimer N, Suetta C, Møller S. Arm lean mass determined by dual-energy X-ray absorptiometry is superior to characterize skeletal muscle and predict sarcopenia-related mortality in cirrhosis. Am J Physiol Gastrointest Liver Physiol 2021;320:G729-40. [PMID: 33729006 DOI: 10.1152/ajpgi.00478.2020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
5 Williams FR, Milliken D, Lai JC, Armstrong MJ. Assessment of the Frail Patient With End-Stage Liver Disease: A Practical Overview of Sarcopenia, Physical Function, and Disability. Hepatol Commun 2021;5:923-37. [PMID: 34141980 DOI: 10.1002/hep4.1688] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
6 Lee CM, Kang BK, Kim M. Radiologic Definition of Sarcopenia in Chronic Liver Disease. Life (Basel) 2021;11:86. [PMID: 33504046 DOI: 10.3390/life11020086] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Lee CM, Kang BK, Kim M. Radiologic Definition of Sarcopenia in Chronic Liver Disease.Life (Basel). 2021;11. [PMID: 33504046 DOI: 10.3390/life11020086.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Han P, Chen X, Yu X, Zhang Y, Song P, Cai M, Liang L, Liang Z, Yang R, Jin F, Wang L, Guo Q. The Predictive Value of Sarcopenia and Its Individual Criteria for Cardiovascular and All-Cause Mortality in Suburb-dwelling Older Chinese. J Nutr Health Aging 2020;24:765-71. [PMID: 32744574 DOI: 10.1007/s12603-020-1390-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
9 Georgiou A, Papatheodoridis GV, Alexopoulou A, Deutsch M, Vlachogiannakos I, Ioannidou P, Papageorgiou MV, Papadopoulos N, Yannakoulia M, Kontogianni MD. Validation of cutoffs for skeletal muscle mass index based on computed tomography analysis against dual energy X-ray absorptiometry in patients with cirrhosis: the KIRRHOS study. Ann Gastroenterol. 2020;33:80-86. [PMID: 31892802 DOI: 10.20524/aog.2019.0432] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
10 Carey EJ, Lai JC, Sonnenday C, Tapper EB, Tandon P, Duarte-Rojo A, Dunn MA, Tsien C, Kallwitz ER, Ng V, Dasarathy S, Kappus M, Bashir MR, Montano-Loza AJ. A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation. Hepatology 2019;70:1816-29. [PMID: 31220351 DOI: 10.1002/hep.30828] [Cited by in Crossref: 108] [Cited by in F6Publishing: 99] [Article Influence: 36.0] [Reference Citation Analysis]
11 Reddy YK, Maliakkal B, Agbim U. Nutrition in Chronic Liver Disease. Curr Treat Options Gastro 2019;17:602-18. [DOI: 10.1007/s11938-019-00252-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
12 Sinclair M. Controversies in Diagnosing Sarcopenia in Cirrhosis-Moving from Research to Clinical Practice. Nutrients. 2019;11:2454. [PMID: 31615103 DOI: 10.3390/nu11102454] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
13 Sinclair M, Chapman B, Hoermann R, Angus PW, Testro A, Scodellaro T, Gow PJ. Handgrip Strength Adds More Prognostic Value to the Model for End-Stage Liver Disease Score Than Imaging-Based Measures of Muscle Mass in Men With Cirrhosis. Liver Transpl. 2019;25:1480-1487. [PMID: 31282126 DOI: 10.1002/lt.25598] [Cited by in Crossref: 27] [Cited by in F6Publishing: 41] [Article Influence: 9.0] [Reference Citation Analysis]
14 Belarmino G, Singer P, Gonzalez M, Machado N, Cardinelli C, Barcelos S, Andraus W, D'albuquerque L, Damiani L, Costa A, Pereira R, Heymsfield S, Sala P, Torrinhas R, Waitzberg D. Prognostic value of energy expenditure and respiratory quotient measuring in patients with liver cirrhosis. Clinical Nutrition 2019;38:1899-904. [DOI: 10.1016/j.clnu.2018.07.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
15 Ooi PH, Hager A, Mazurak VC, Dajani K, Bhargava R, Gilmour SM, Mager DR. Sarcopenia in Chronic Liver Disease: Impact on Outcomes. Liver Transpl. 2019;25:1422-1438. [PMID: 31242345 DOI: 10.1002/lt.25591] [Cited by in Crossref: 33] [Cited by in F6Publishing: 50] [Article Influence: 11.0] [Reference Citation Analysis]
16 Lindqvist C, Brismar TB, Majeed A, Wahlin S. Assessment of muscle mass depletion in chronic liver disease: Dual-energy x-ray absorptiometry compared with computed tomography. Nutrition 2019;61:93-8. [DOI: 10.1016/j.nut.2018.10.031] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
17 Santos LA, Lima TB, Ietsugu MDV, Nunes HRDC, Qi X, Romeiro FG. Anthropometric measures associated with sarcopenia in outpatients with liver cirrhosis. Nutr Diet 2019;76:613-9. [DOI: 10.1111/1747-0080.12523] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
18 Chang KV, Chen JD, Wu WT, Huang KC, Han DS. Association of loss of muscle mass with mortality in liver cirrhosis without or before liver transplantation: A systematic review and meta-analysis. Medicine (Baltimore) 2019;98:e14373. [PMID: 30817561 DOI: 10.1097/MD.0000000000014373] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
19 Duarte-Rojo A, Ruiz-Margáin A, Montaño-Loza AJ, Macías-Rodríguez RU, Ferrando A, Kim WR. Exercise and physical activity for patients with end-stage liver disease: Improving functional status and sarcopenia while on the transplant waiting list. Liver Transpl 2018;24:122-39. [PMID: 29024353 DOI: 10.1002/lt.24958] [Cited by in Crossref: 73] [Cited by in F6Publishing: 89] [Article Influence: 18.3] [Reference Citation Analysis]